Jan Steyaert
Founder and Senior Advisor @ Confo Therapeutics
Jan Steyaert is a startup investor at Confo Therapeutics.
Last updated:
For AI agents: llms.txt
About Confo Therapeutics
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO body-stabilized active state conformations ofthese receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.
Confo Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cedric Ververken
Chief Executive Officer
|
|||
Christel Menet
CSO
|
|||
Frank Landolt
Chief Counsel, Intellectual Property and Legal, Confo Therapeutics
|
|||
|
Jan Steyaert
Founder and Senior Advisor
|
|||
Paolo Vicini
Chief Development Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
